Furthermore, SMOM2 induced upregulation of Wnt/β-catenin signaling, as shown by increased nuclear β-catenin and lymphoid enhancer-binding factor-1 (LEF1) expression, which led to mice BCC and human BCC tumor initiation [66]. The gene discussed is LEF1; the disease is neoplasm.